Search

everythinglearnresearchcommunity

for

Search:↓

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

The study aims to find the most effective treatments for male pattern baldness.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

The updated NPRT system now covers different types of hair loss in men and women.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

Hormones and iron deficiency are linked to female pattern hair loss, and hair thinning patterns are similar across different types of this condition.

Male-pattern baldness has a weak link to heart disease and some related health conditions.

Increased androgen receptor expression in certain hair follicle areas may cause male pattern baldness.

Micrografts can grow natural hair and most patients are satisfied, but some need multiple procedures.

Surgical hair replacement is a viable option for male pattern baldness when done with proper planning and realistic expectations.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Trichoscopic measurements help determine the severity of female pattern hair loss.

Trichoscopy effectively distinguishes between severe and mild male pattern hair loss.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Genetic differences in hair loss can help improve diagnosis and treatment.

Minoxidil effectively regrows hair in male pattern baldness.

Short scalp flaps are easier but not good for severe baldness; Juri flaps are complex but better for density and coverage.

The understanding of male-pattern baldness remains unclear.

Young men with male pattern baldness lose hair density over time without treatment.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Injecting platelet-rich plasma (PRP) can increase hair growth rate and density in male pattern baldness.

The study tested a hair treatment and found it can help grow hair, but won't stop baldness. It's safe and works well, but needs more testing.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Researchers created a new system to classify male baldness, finding six types and a common hairline shape, to improve hair loss treatments.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

Early baldness is noticed due to both reduced hair density and thinner hair shafts.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.